Emerging biomarkers in the detection and prognosis of prostate ...

Active Surveillance in Prostate Cancer: Current and Potentially ...

Summary: This review article addresses the characteristics of the current and emerging PCa prognostic biomarkers, including tests available for ...

New Molecular Biomarkers for the Prognosis and Management of ...

Therefore, PSA is now commonly regarded as an indicator of prostate volume and is not independently diagnostic or prognostic in prostate cancer. Due to these ...

Biomarkers & Genomic Testing - ZERO Prostate Cancer

Biomarker testing in prostate cancer looks at how certain sets of genes in the tumor interact and function. It can be performed on both biopsy tissue and on ...

Biomarkers for Diagnosis and Prognosis of Prostate Cancer

Biomarkers for prostate cancer diagnosis and subsequent prognostic screening have significantly advanced this field. Here, we review some of the current blood, ...

Emerging biomarkers and techniques in prostate cancer diagnosis

Dr. Leonard G. Gomella discusses emerging biomarkers and the use of MRI for the early detection of prostate cancer.

Genomic and Phenotypic Biomarkers for Precision Medicine ...

Metastatic prostate cancer (mPCa) comprises a spectrum of diverse genotypes and phenotypes. Notwithstanding advances in screening and treatment ...

Cancer biomarkers: Emerging trends and clinical implications for ...

This assay is applied in clinical studies for screening (e.g., serum prostate-specific antigen [PSA] in prostate cancer), diagnosis (e.g., ...

Current and emerging biomarkers in breast cancer: prognosis and ...

In addition to the classical clinical prognostic factors of breast cancer, established molecular biomarkers such as estrogen receptor and ...

Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis ...

Most prostate cancers are first found during screening with a prostate-specific antigen (PSA) blood test, alone or in combination with a digital rectal exam, ...

New Prostate Cancer Biomarkers: The Search Continues

For detection of any cancer on biopsy, the IsoPSA assay had significantly better receiver operating characteristics (area under the curve [AUC] ...

Recent advances and future perspectives in the therapeutics of ...

Prostate-specific antigen (PSA) is a revolutionary discovery for the identification of PC. However, it has led to an increase in over diagnosis ...

Clinical utility of current biomarkers for prostate cancer detection

Active surveillance (AS) has emerged as an alternative treatment option for men with early-stage disease, in which any kind of definitive ...

MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased ...

However, PSA is a screening test, and is not diagnostic of either prostate cancer or of prostate cancer requiring immediate intervention. The diagnosis relies ...

New Biomarkers to Measure Prostate Cancer Risk Save Men Time ...

A new wave of biomarker testing that measure assays in the urine, blood and tissue can help better detect prostate cancer and, in certain cases, save men.

Molecular Markers in Prostate Cancer Detection and Prognosis

biomarker studies. • To review the available and emerging biomarkers in different prostate cancer disease states. • To present the future directions in ...

Diagnostic Biomarkers of Prostate Cancer in 2023 and Beyond

... biomarkers in the field of prostate cancer diagnosis ... 273 ‒ Prostate health: common problems, cancer prevention, screening, treatment, and more.

Urine as an emerging liquid biopsy for prostate cancer biomarker ...

The most commonly used tests for prostate cancer detection are the prostate-specific antigen (PSA) blood test, an MRI, and/or a biopsy (3). Non-cancerous ...

The PSA and beyond: An update on prostate cancer biomarkers

After diagnosis, it can help gauge how aggressive the cancer is; after initial treatment, it can reveal whether the cancer has returned; and in patients with ...

A New Urine Test May ID the Deadliest Prostate Cancers

If mpMRI isn't available, the guidelines call for biomarker testing to determine the risk of having prostate cancer before a biopsy. Currently, there are 6 ...

A review of current clinical biomarkers for prostate cancer

The current 'gold standard' for the diagnosis of prostate cancer is a prostate biopsy and the decision on when to biopsy a patient with non-suspicious Digital ...